FierceBiotech

BioMarin Pharmaceutical Inc. Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral ...

NOVATO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. today announced results from its Phase 2 multi-center, randomized, double-blind, placebo ...